# REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial

> **NCT00319150** · PHASE3 · TERMINATED · sponsor: **Queen's University** · enrollment: 6 (actual)

## Conditions studied

- Kidney Failure, Chronic
- Drug Resistance

## Interventions

- **DRUG:** erythropoietin

## Key facts

- **NCT ID:** NCT00319150
- **Lead sponsor:** Queen's University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** New evidence and trouble recruiting
- **Last updated:** 2009-02-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00319150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00319150, "REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00319150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*